Evidence map›Paper›PMID 27832418›Full record

ReviewReviews in endocrine & metabolic disorders2016

Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

K Karimi, T H Lindgren, C A Koch, Robert T Brodell

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Clinicopathological implications of miR-3127 in melanoma.Journal of pathology and translational medicine · 2025
    Article
  5. Change in Metabolic Markers and the Risk of Skin Cancer: Results from the Lifelines Cohort Study in the Netherlands.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. New Insights into the Link Between Melanoma and Obesity.Advances in experimental medicine and biology · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. A Meta-Analysis Study to Infer Voltage-Gated KAntioxidants (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

K KarimiSchool of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
T H LindgrenSchool of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
C A KochDivision of Endocrinology, University of Mississippi Medical Center, Jackson, MS, USA.
Robert T BrodellDepartment of Dermatology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, USA. rbrodell@umc.edu.
University of Mississippi Medical Center · USTexas Tech University · USTexas Tech University Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dramatic increases in incidence of both obesity and many cancers including skin cancer emphasize the need to better understand the pathophysiology of both conditions and their connections. Melanoma is considered the fastest growing cancer and rates of non-melanoma skin cancer have also increased over the last decade. The molecular mechanisms underlying the association between obesity and skin cancer are not clearly understood but emerging evidence points to changes in the tumor microenvironment including aberrant cell signaling and genomic instability in the chronic inflammatory state many obese individuals experience. This article reviews the literature linking obesity to melanoma and non-melanoma skin cancer.

Indexed as

MelanomaObesitySkin NeoplasmsHumansBasal cell carcinomaInflammationInsulinLeptinMelanomaNon-melanoma skin cancerObesitySquamous cell carcinoma

Identifiers

PMID27832418
OpenAlexW2553736672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.